Hepalatide not checked
Shanghai HEP Pharmaceutical Co., Ltd. · L47
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Continuous treatment with hepalatide 2.1mg sc, qd, for 48 weeks”In the company’s words, NCT07309380 on ClinicalTrials.gov
- Tested for
- Hepatitis D, Chronic
- Main trialPhase 3
- “This study adopts a multicenter, randomized, double-blind, placebo-parallel controlled design to evaluate the efficacy and safety of L47 in the treatment of chronic hepatitis D. A total of 150 subjects are planned to be enrolled. After passing the screening, they will be randomly assigned to the L47 group or the placebo group at a ratio of 2:1, with liver cirrhosis and subjects' regional distribution as stratification factors. The two groups will receive hepratide (2.1 mg/day) or placebo, respectively. Upon completion of the 48-week double-blind treatment phase, all subjects in each group…”In the company’s words, NCT07309380 on ClinicalTrials.gov
- Other names
- L47 · HLT
Other drugs for Hepatitis D, Chronic
- ElebsiranVir Biotechnology, Inc. · Phase 3
- TobevibartVir Biotechnology, Inc. · Phase 3
- BrelovitugMirum Pharmaceuticals, Inc. · Phase 2/3
- GS-4321Gilead (Kite) · Phase 1/2
- RBD1016Ribocure Pharmaceuticals AB · Phase 2
Coming up1
- Jun 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Not yet recruiting | Jun 2028 | Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D | |
| Phase 2Completed | 1 Nov 2023 | A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B | |
| Phase 2Completed | 30 Jan 2024 | Study of Hepalatide in Chronic Hepatitis D(CHD) Patients | |
| Phase 2Completed | 24 Jun 2024 | A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients | |
| Phase 2Completed | 1 May 2026 | A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D | |
| Phase 1/2Withdrawn | Dec 2025 | A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026